Ohr Pharmaceutical Inc.
Aminosteroids for the Treatment of a PTP1B Associated Disease
Last updated:
Abstract:
This application is directed to the use of aminosteroid compounds for the selective inhibition of the enzyme PTP1B in a mammal for the treatment of diabetes.
Status:
Application
Type:
Utility
Filling date:
30 Jan 2020
Issue date:
27 Aug 2020